JG
SGHT icon

Joel Greenblatt’s Sight Sciences SGHT Stock Holding History

Joel Greenblatt’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-156,471
Closed -$10.6M – 1807
2025
Q2 		$10.6M Buy
156,471
+60,582
+63% +$202K 0.06% 454
2025
Q1 		$5.74M Buy
+95,889
New +$270K 0.05% 493

Other funds holding SGHT

KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AMH
Apollo Management Holdings New York $8.94B AUM 120.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Joel Greenblatt's SGHT Position: Q3 2025 in Review

Joel Greenblatt sold out of Sight Sciences (SGHT) in Q3 2025, closing a stake of 156,471 shares — an estimated $10.6M sold.

Joel Greenblatt first reported a position in SGHT in Q1 2025 and held it in 2 quarters. The position peaked at $10.6M in Q2 2025. 84 funds tracked by Wall St. Rank hold SGHT as of Q3 2025.

  • Joel Greenblatt reported no remaining Sight Sciences position as of Q3 2025 after selling out during the quarter.
  • Joel Greenblatt sold 156,471 Sight Sciences shares in Q3 2025, an estimated $10.6M.
  • Joel Greenblatt first reported a position in Sight Sciences in Q1 2025 and held it in 2 quarters.
  • Joel Greenblatt's Sight Sciences position peaked at $10.6M in Q2 2025.
  • 84 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2025.

Based on Gotham Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.